论文部分内容阅读
目的探讨增生性糖尿病视网膜病变(PDR)玻璃体视网膜手术同期联合白内障超声乳化人工晶状体(IOL)植入术与二期硅油取出联合白内障超声乳化吸除IOL植入术的术后炎症反应差异。设计回顾性病例对照研究。研究对象同期或二期行白内障手术的PDR伴牵拉性视网膜脱离或玻璃体积血者接受玻璃体视网膜手术联合硅油填充者91例104眼。方法术后平均随访6个月。同时联合白内障超声乳化吸除IOL植入手术(同期组)52眼,二期行白内障超声乳化吸除IOL植入联合硅油取出手术(二期组)52眼。分析两组间患眼术后视力、前节炎症反应程度的差异。主要指标视力及眼前节炎症反应。结果同期组及二期组患眼术后最佳矫正视力>0.1以上者分别为14/52、8152眼(X~2=-6.87,P=0.07);同期组及二期组患眼术后1周内出现角膜水肿分别为16/52、6/52眼(X~2=11.53,P=0.001);同期组及二期组患眼术后出现角膜后沉着物分别为20152、9/52眼(X~2=5.79.P= 0.019)。结论玻璃体视网膜手术一期联合白内障超声乳化吸除IOL植入术后眼前节炎症反应较严重。
Objective To investigate the postoperative inflammatory response of proliferative diabetic retinopathy (PDR) vitreoretinal surgery combined with cataract phacoemulsification intraocular lens (IOL) implantation and secondary silicone oil extraction combined with cataract phacoemulsification and IOL implantation. Design retrospective case-control study. Participants 91 patients (104 eyes) with vitreoretinal surgery and vitreoretinal surgery underwent PDR with traction retinal detachment or vitreous hemorrhage during cataract surgery. Methods The patients were followed up for an average of 6 months. At the same time, 52 eyes underwent phacoemulsification with IOL implantation (same period group) and 52 eyes underwent phacoemulsification with IOL implantation combined with silicone oil removal surgery (stage II group). Analysis of visual acuity between the two groups after surgery, anterior section of the degree of inflammatory response differences. The main indicators of visual acuity and anterior segment inflammation. Results In the same group and the second group, the best corrected visual acuity> 0.1 after operation was 14 / 52,8152 eyes (X ~ 2 = -6.87, P = 0.07) Corneal edema in one week was 16/52, 6/52, respectively (X ~ 2 = 11.53, P = 0.001) Eye (X ~ 2 = 5.79.P = 0.019). Conclusion The vitreous retinal surgery combined with cataract phacoemulsification IOL implantation in the anterior segment inflammation more serious.